System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Ahead of print

PubMed: 40664527 DOI: 10.1016/j.acvd.2025.06.069

Immune checkpoint inhibitor rechallenge after myocarditis: Time for reappraisal?

Arch Cardiovasc Dis

Authors: Guillaume Bailly, Ariel Cohen, Franck Boccara, Joe-Elie Salem

Affiliations

  • Department of Cardiology, Saint-Antoine and Tenon Hospital, AP-HP, Sorbonne Université, 75012 Paris, France; Sorbonne University, AP-HP, Inserm, CIC-1901, Department of Pharmacology, Groupe Hospitalier Pitié-Salpêtrière, 75013 Paris, France.
  • Department of Cardiology, Saint-Antoine and Tenon Hospital, AP-HP, Sorbonne Université, 75012 Paris, France.
  • Department of Cardiology, Saint-Antoine and Tenon Hospital, AP-HP, Sorbonne Université, 75012 Paris, France; GRC 22, Complications Cardiovasculaires et Métaboliques chez les patients vivant avec le VIH (C(2)MV), Sorbonne Université, 75012 Paris, France.
  • Sorbonne University, AP-HP, Inserm, CIC-1901, Department of Pharmacology, Groupe Hospitalier Pitié-Salpêtrière, 75013 Paris, France.

MeSH

Cardiovascular Diseases, Immune Checkpoint Inhibitors, Myocarditis